Journal article
Proceedings of a Consensus Conference: Pathogen Inactivation—Making Decisions About New Technologies
Abstract
Significant progress has been made in reducing the risk of pathogen transmission to transfusion recipients. Nonetheless, there remains a continuing risk of transmission of viruses, bacteria, protozoa, and prions to recipients. These include many of the viruses for which specific screening tests exist as well as pathogens for which testing is currently not being done, including various species of bacteria, babesiosis, variant Creutzfeld-Jacob …
Authors
Webert KE; Cserti CM; Hannon J; Lin Y; Pavenski K; Pendergrast JM; Blajchman MA
Journal
Transfusion Medicine Reviews, Vol. 22, No. 1, pp. 1–34
Publisher
Elsevier
Publication Date
1 2008
DOI
10.1016/j.tmrv.2007.09.001
ISSN
0887-7963
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AnimalsAnti-Infective AgentsBlood PlateletsBlood TransfusionBlood-Borne PathogensClinical Laboratory TechniquesCost-Benefit AnalysisDecision MakingErythrocytesEuropeHumansMedical Laboratory ScienceMicrobial ViabilityPublic HealthTransfusion ReactionTransplantationTreatment OutcomeUnited StatesUnited States Food and Drug Administration